Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 37 non-cytoplasmic 38 60 transmembrane 61 83 cytoplasmic 84 102 transmembrane 103 125 non-cytoplasmic 126 146 transmembrane 147 155 cytoplasmic 156 179 transmembrane 180 196 non-cytoplasmic 197 218 transmembrane 219 238 cytoplasmic 239 261 transmembrane 262 291 non-cytoplasmic 292 312 transmembrane 313 343 cytoplasmic 344 363 transmembrane 364 382 non-cytoplasmic 383 400 transmembrane 401 413 cytoplasmic 414 435 transmembrane 436 446 non-cytoplasmic 447 470 transmembrane 471 476 cytoplasmic
Input: >15023 FitnessBrowser__Keio:15023 MAGNVQEKQLRWYNIALMSFITVWGFGNVVNNYANQGLVVVFSWVFIFALYFTPYALIVG QLGSTFKDGKGGVSTWIKHTMGPGLAYLAAWTYWVVHIPYLAQKPQAILIALGWAMKGDG SLIKEYSVVALQGLTLVLFIFFMWVASRGMKSLKIVGSVAGIAMFVMSLLYVAMAVTAPA ITEVHIATTNITWETFIPHIDFTYITTISMLVFAVGGAEKISPYVNQTRNPGKEFPKGML CLAVMVAVCAILGSLAMGMMFDSRNIPDDLMTNGQYYAFQKLGEYYNMGNTLMVIYAIAN TLGQVAALVFSIDAPLKVLLGDADSKYIPASLCRTNASGTPVNGYFLTLVLVAILIMLPT LGIGDMNNLYKWLLNLNSVVMPLRYLWVFVAFIAVVRLAQKYKPEYVFIRNKPLAMTVGI WCFAFTAFACLTGIFPKMEAFTAEWTFQLALNVATPFVLVGLGLIFPLLARKANSK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server